AGA Medical (AGAM) Sees IPO Price of $15-$16
More News related to AGAM
- AGA Medical Adds Jack P. Helms to Board of Directors
- AGA Medical Receives Product Approvals in China
- Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
- AGA Medical Wins Injunction Against Occlutech's Figulla Flex
- AGA Medical to Webcast Third-Quarter Earnings Conference Call Tuesday, Nov. 3
AGA Medical Holdings (Nasdaq: AGAM) has filed an amended registration statement with the SEC for an initial public offering of its common stock. The Company is offering 13,750,000 shares and expects the offering price to be between $15-$16 per share. The Company plans to list on the NASDAQ under the symbol "AGAM".
The offering is being made through BofA Merrill Lynch, Citi, Deutsche Bank, Leerink Swann, Wells Fargo and Natixis Bleichroeder.
AGA is an innovator and manufacturer of medical devices for the treatment of structural heart defects and vascular diseases. It's AMPLATZER occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be highly effective in defect closure.
Related Categories
IPOsStocks Mentioned
-0.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
